TY - JOUR AU - Siegel, R. L. AU - Miller, K. D. AU - Jemal, A. PY - 2018 DA - 2018// TI - Cancer statistics, 2018 JO - CA Cancer J Clin VL - 68 UR - https://doi.org/10.3322/caac.21442 DO - 10.3322/caac.21442 ID - Siegel2018 ER - TY - JOUR AU - Zhang, L. AU - Sanagapalli, S. AU - Stoita, A. PY - 2018 DA - 2018// TI - Challenges in diagnosis of pancreatic cancer JO - World J Gastroenterol. VL - 24 UR - https://doi.org/10.3748/wjg.v24.i19.2047 DO - 10.3748/wjg.v24.i19.2047 ID - Zhang2018 ER - TY - JOUR AU - Hartwig, W. AU - Werner, J. AU - Jager, D. AU - Debus, J. AU - Buchler, M. W. PY - 2013 DA - 2013// TI - Improvement of surgical results for pancreatic cancer JO - Lancet Oncol. VL - 14 UR - https://doi.org/10.1016/S1470-2045(13)70172-4 DO - 10.1016/S1470-2045(13)70172-4 ID - Hartwig2013 ER - TY - JOUR AU - Evans, D. B. AU - Varadhachary, G. R. AU - Crane, C. H. AU - Sun, C. C. AU - Lee, J. E. AU - Pisters, P. W. PY - 2008 DA - 2008// TI - Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head JO - J Clin Oncol. VL - 26 UR - https://doi.org/10.1200/JCO.2007.15.8634 DO - 10.1200/JCO.2007.15.8634 ID - Evans2008 ER - TY - JOUR AU - Moore, M. J. PY - 2005 DA - 2005// TI - Brief communication: a new combination in the treatment of advanced pancreatic cancer JO - Semin Oncol. VL - 32 UR - https://doi.org/10.1053/j.seminoncol.2005.07.017 DO - 10.1053/j.seminoncol.2005.07.017 ID - Moore2005 ER - TY - JOUR AU - Hammel, P. AU - Huguet, F. AU - van Laethem, J. L. AU - Goldstein, D. AU - Glimelius, B. AU - Artru, P. PY - 2016 DA - 2016// TI - Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: the LAP07 randomized clinical trial JO - JAMA. VL - 315 UR - https://doi.org/10.1001/jama.2016.4324 DO - 10.1001/jama.2016.4324 ID - Hammel2016 ER - TY - JOUR AU - Dahan, L. AU - Bonnetain, F. AU - Ychou, M. AU - Mitry, E. AU - Gasmi, M. AU - Raoul, J. L. PY - 2010 DA - 2010// TI - Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301) JO - Gut. VL - 59 UR - https://doi.org/10.1136/gut.2010.216135 DO - 10.1136/gut.2010.216135 ID - Dahan2010 ER - TY - JOUR AU - Jin, Z. AU - Du, Y. AU - Li, Z. AU - Jiang, Y. AU - Chen, J. AU - Liu, Y. PY - 2008 DA - 2008// TI - Endoscopic ultrasonography-guided interstitial implantation of iodine 125-seeds combined with chemotherapy in the treatment of unresectable pancreatic carcinoma: a prospective pilot study JO - Endoscopy. VL - 40 UR - https://doi.org/10.1055/s-2007-995476 DO - 10.1055/s-2007-995476 ID - Jin2008 ER - TY - JOUR AU - Wyse, J. M. AU - Carone, M. AU - Paquin, S. C. AU - Usatii, M. AU - Sahai, A. V. PY - 2011 DA - 2011// TI - Randomized, double-blind, controlled trial of early endoscopic ultrasound-guided celiac plexus neurolysis to prevent pain progression in patients with newly diagnosed, painful, inoperable pancreatic cancer JO - J Clin Oncol. VL - 29 UR - https://doi.org/10.1200/JCO.2010.32.2750 DO - 10.1200/JCO.2010.32.2750 ID - Wyse2011 ER - TY - JOUR AU - Sanders, M. K. AU - Moser, A. J. AU - Khalid, A. AU - Fasanella, K. E. AU - Zeh, H. J. AU - Burton, S. PY - 2010 DA - 2010// TI - EUS-guided fiducial placement for stereotactic body radiotherapy in locally advanced and recurrent pancreatic cancer JO - Gastrointest Endosc. VL - 71 UR - https://doi.org/10.1016/j.gie.2009.12.020 DO - 10.1016/j.gie.2009.12.020 ID - Sanders2010 ER - TY - JOUR AU - van der Gaag, N. A. AU - Rauws, E. A. AU - van Eijck, C. H. AU - Bruno, M. J. AU - van der Harst, E. AU - Kubben, F. J. PY - 2010 DA - 2010// TI - Preoperative biliary drainage for cancer of the head of the pancreas JO - N Engl J Med. VL - 362 UR - https://doi.org/10.1056/NEJMoa0903230 DO - 10.1056/NEJMoa0903230 ID - van der Gaag2010 ER - TY - JOUR AU - Hanahan, D. AU - Weinberg, R. A. PY - 2011 DA - 2011// TI - Hallmarks of cancer: the next generation JO - Cell. VL - 144 UR - https://doi.org/10.1016/j.cell.2011.02.013 DO - 10.1016/j.cell.2011.02.013 ID - Hanahan2011 ER - TY - JOUR AU - Bailey, P. AU - Chang, D. K. AU - Nones, K. AU - Johns, A. L. AU - Patch, A. M. AU - Gingras, M. C. PY - 2016 DA - 2016// TI - Genomic analyses identify molecular subtypes of pancreatic cancer JO - Nature. VL - 531 UR - https://doi.org/10.1038/nature16965 DO - 10.1038/nature16965 ID - Bailey2016 ER - TY - STD TI - ClinicalTrials.gov. NCT02472977: Safety and efficacy study of ulocuplumab and nivolumab in subjects with solid tumors (CXCessoR4). https://clinicaltrials.gov/ct2/show/NCT02472977. Accessed 26 Oct 2018. UR - https://clinicaltrials.gov/ct2/show/NCT02472977 ID - ref14 ER - TY - JOUR AU - Waddell, N. AU - Pajic, M. AU - Patch, A. M. AU - Chang, D. K. AU - Kassahn, K. S. AU - Bailey, P. PY - 2015 DA - 2015// TI - Whole genomes redefine the mutational landscape of pancreatic cancer JO - Nature. VL - 518 UR - https://doi.org/10.1038/nature14169 DO - 10.1038/nature14169 ID - Waddell2015 ER - TY - JOUR AU - Van Cutsem, E. AU - Vervenne, W. L. AU - Bennouna, J. AU - Humblet, Y. AU - Gill, S. AU - Van Laethem, J. L. PY - 2009 DA - 2009// TI - Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer JO - J Clin Oncol. VL - 27 UR - https://doi.org/10.1200/JCO.2008.20.0238 DO - 10.1200/JCO.2008.20.0238 ID - Van Cutsem2009 ER - TY - JOUR AU - Beatty, G. L. AU - O'Hara, M. H. AU - Lacey, S. F. AU - Torigian, D. A. AU - Nazimuddin, F. AU - Chen, F. PY - 2018 DA - 2018// TI - Activity of mesothelin-specific chimeric antigen receptor T cells against pancreatic carcinoma metastases in a phase 1 trial JO - Gastroenterology. VL - 155 UR - https://doi.org/10.1053/j.gastro.2018.03.029 DO - 10.1053/j.gastro.2018.03.029 ID - Beatty2018 ER - TY - JOUR AU - Kaur, S. AU - Sharma, N. AU - Krishn, S. R. AU - Lakshmanan, I. AU - Rachagani, S. AU - Baine, M. J. PY - 2014 DA - 2014// TI - MUC4-mediated regulation of acute phase protein lipocalin 2 through HER2/AKT/NF-kappaB signaling in pancreatic cancer JO - Clin Cancer Res. VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-13-2174 DO - 10.1158/1078-0432.CCR-13-2174 ID - Kaur2014 ER - TY - JOUR AU - Li, M. AU - Zhang, Y. AU - Liu, Z. AU - Bharadwaj, U. AU - Wang, H. AU - Wang, X. PY - 2007 DA - 2007// TI - Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression JO - Proc Natl Acad Sci U S A. VL - 104 UR - https://doi.org/10.1073/pnas.0709307104 DO - 10.1073/pnas.0709307104 ID - Li2007 ER - TY - JOUR AU - Zhang, Y. AU - Yang, J. AU - Cui, X. AU - Chen, Y. AU - Zhu, V. F. AU - Hagan, J. P. PY - 2013 DA - 2013// TI - A novel epigenetic CREB-miR-373 axis mediates ZIP4-induced pancreatic cancer growth JO - EMBO Mol Med. VL - 5 UR - https://doi.org/10.1002/emmm.201302507 DO - 10.1002/emmm.201302507 ID - Zhang2013 ER - TY - STD TI - Yang J, Zhang Z, Zhang Y, Ni X, Zhang G, Cui X, et al. ZIP4 promotes muscle wasting and cachexia in mice with orthotopic pancreatic tumors by stimulating RAB27B-regulated release of extracellular vesicles from cancer cells. Gastroenterology. 2018. doi: 10.1053/j.gastro.2018.10.026. ID - ref21 ER -